[1]

GAI Linlin, LI Haibo, CHU Jinjin, SUN Jiamei, YAN Xinyi, DU Jinke, DAI Wenqing, XU Donghua. Role of chemiluminescence interferon gamma release assay in auxiliary diagnosis of pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(3): 257-260.

[2]

JU Yinghui, MO Huifang, WU Hui, CHEN Pu, GUO Wei, WANG Beili. Performance comparison of lymphocyte subset determination by 6-color flow cytometry with 2 different reagents [J]. Laboratory Medicine, 2022, 37(3): 270-273.

[3]

ZHANG Cheng, YANG Ying, WU Shanshan, LÜ Dan, ZHANG Tingting. Role of multiplexed bead-based immunoassay in the determination of AAV [J]. Laboratory Medicine, 2019, 34(7): 633-636.

[4]

CHEN Kai, HAN Yan, YIN Yueping, ZHONG Mingying, ZHU Bangyong, SHI Meiqin. Parallel comparison of 7 kinds of domestic Chlamydia trachomatis nucleic acid test reagents [J]. Laboratory Medicine, 2018, 33(12): 1081-1085.

[5]

[6]

[7]

YANG Huikuan, YUAN Zhaohu, CHEN Xiaojie, WEI Yaming, CHEN Dandan. Inhibition of DC-CIK VISTA signal for improving the anti-tumor effect of malignant tumor cells [J]. Laboratory Medicine, 2018, 33(10): 933-937.

[8]

WEI Yancai, ZHENG Weiling, SHI Yan, SONG Miaoli, YE Kexue, LU Xun, YANG Chen. Consistency of electrochemiluminescence and 2 domestic chemiluminescence determination systems in CA72-4 determination [J]. Laboratory Medicine, 2018, 33(9): 830-834.

[9]

. 123456 [J]. Laboratory Medicine, 2018, 33(8): 770-771.

[10]

[11]

XIAO Linlin, DU Ying, LIU Weiwei, WEI Quhao, FENG Jing. Optimization and monitoring for pre-analysis process in medical laboratory accreditation [J]. Laboratory Medicine, 2018, 33(4): 343-347.

[12]

[13]

HU Yuyi, WU Hui, HAN Xu, ZHANG Chunyan, GUO Wei, LOU Wenhui, PAN Baishen. Performance of double-antibody sandwich ELISA for chromogranin A determination [J]. Laboratory Medicine, 2018, 33(1): 55-59.

[14]

. [J]. Laboratory Medicine, 2018, 33(1): 88-90.

[15]

QIN Juanxiu, ZHANG Haomin, LIU Qian, XIA Qiang, LI Min. Performance of C. DIFF QUICK CHEK COMPLETE [J]. Laboratory Medicine, 2017, 32(12): 1152-1155.

组别	例数	股骨颈区	Ward' s 三角区	大转子区	腰椎
组别	例数	股骨颈区	Ward' s 三角区	大转子区	L2	L3	L4
正常对照组	60	0.79±0.24	0.67±0.16	0.58±0.11	0.98±0.13	1.05±0.19	1.02±0.21
RA组	60	0.86±0.12^*	0.75±0.25^*	0.72±0.18^*	1.12±0.12^*	1.19±0.22^*	1.20±0.17^*

组别	例数	股骨颈区	Ward' s 三角区	大转子区	腰椎
组别	例数	股骨颈区	Ward' s 三角区	大转子区	L2	L3	L4
正常对照组	60	0.79±0.24	0.67±0.16	0.58±0.11	0.98±0.13	1.05±0.19	1.02±0.21
RA组	60	0.86±0.12^*	0.75±0.25^*	0.72±0.18^*	1.12±0.12^*	1.19±0.22^*	1.20±0.17^*

组别	例数	B-ALP（µg/L）	TRACP-5b（U/L）
正常对照组	60	21.25±2.24	2.15±0.35
RA组	60	16.53±2.69^*	3.73±0.41^*
骨量正常组	13	18.62±1.25^*	2.57±0.22^*
骨量减少组	25	16.76±1.87^*#	3.64±0.37^*#
OP组	22	15.13±1.19^*#△	4.29±0.28^*#△

组别	例数	B-ALP（µg/L）	TRACP-5b（U/L）
正常对照组	60	21.25±2.24	2.15±0.35
RA组	60	16.53±2.69^*	3.73±0.41^*
骨量正常组	13	18.62±1.25^*	2.57±0.22^*
骨量减少组	25	16.76±1.87^*#	3.64±0.37^*#
OP组	22	15.13±1.19^*#△	4.29±0.28^*#△

RichHTML

PDF (PC)

[1]	MURARIU R V,MACOVEI L A,BRUJBU I C.Osteoporosis in rheumatoid arthritis[J]. Rev Med Chir Soc Med Nat Lasi,2013,117(2):394-403.
[2]	BULTINK I E,BADEN M,LEMS W F.Glucocorticoid-induced osteoporosis:an update on current pharmacotherapy and future directions[J]. Expert Opin Pharmacother,2013,14(2):185-197.
[3]	中国人骨质疏松症建议诊断标准(第二稿)[J]. 中国骨质疏松杂志,2000,6(1):1-3.
[4]	PRIORESCHI A,MAKDA M A,TIKLY M,et al.Habitual physical activity,sedentary behaviour and bone health in rheumatoid arthritis[J]. Int J Sports Med,2015,36(12):1021-1026.
[5]	沈春燕,王云芳,王正良,等. 骨碱性磷酸酶活性检测在小儿佝偻病筛查中的价值[J]. 检验医学,2013, 28(5):429.
[6]	马晓旭,李春,左瑜,等. Dickkopf-1与抗酒石酸酸性磷酸酶5b在类风湿关节炎骨破坏中的意义[J]. 中日友好医院学报,2014,28(3):134-138.